New York S 1917: Establishes an emergency insulin program

Status: REPORTED AND COMMITTED TO FINANCE (as of 2026-05-05)

State: New York · Session: 2025-2026 · Bill: S 1917

Sponsors: Gustavo Rivera, Andrew Gounardes, Liz Krueger, Luis R. Sepúlveda, Roxanne J. Persaud, Samra Brouk, Zellnor Myrie

Bill Text

Bill Search and Legislative Information | New York State Assembly 

• 

• 

• 

• 

• 

• 

• 

• 

 Skip to main content 

 New York State Assembly

 Speaker Carl E. Heastie

 --> 
 --> 

 --> 

• 
 Assembly Members 

• 
 Legislative Info 

• 
 Public Hearings 

• 
 Speaker's Press 

• 
 Assembly Reports 

• 
 Committees & More 

• Bill Search Home
• Laws
• Legislative Calendar
• Public Hearing Schedule
• Assembly Calendars
• Assembly Committee Agenda 

 Javascript must be enabled to properly view this page. 

 Bill No.: 

• Summary 
• Actions 
• Committee&nbspVotes 
• Floor&nbspVotes 
• Memo 
• Text 
• LFIN 
• Chamber&nbspVideo/Transcript 
S01917 Summary:

BILL NOS01917A

&nbsp

SAME ASNo Same As

&nbsp

SPONSORRIVERA

&nbsp

COSPNSRBROUK, GOUNARDES, KRUEGER, MYRIE, PERSAUD, SEPULVEDA

&nbsp

MLTSPNSR

&nbsp

Add Art 28-CC §2894, Pub Health L; add §95-l, St Fin L

&nbsp

Establishes an emergency insulin program and corresponding emergency insulin program trust fund to facilitate emergency access to analog insulins.

Go to top S01917 Actions:

BILL NOS01917A

&nbsp

01/14/2025REFERRED TO HEALTH

01/07/2026REFERRED TO HEALTH

04/21/2026AMEND AND RECOMMIT TO HEALTH

04/21/2026PRINT NUMBER 1917A

05/05/2026REPORTED AND COMMITTED TO FINANCE

Go to topS01917 Committee&nbspVotes:

Go to topS01917 Floor&nbspVotes:

There are no Assembly votes for this bill in this legislative session.

Go to topS01917 Text:

 STATE OF NEW YORK
 ________________________________________________________________________

 1917--A

 2025-2026 Regular Sessions

 IN SENATE

 January 14, 2025
 ___________

 Introduced by Sens. RIVERA, BROUK, GOUNARDES, KRUEGER, MYRIE, PERSAUD,
 SEPULVEDA -- read twice and ordered printed, and when printed to be
 committed to the Committee on Health -- recommitted to the Committee
 on Health in accordance with Senate Rule 6, sec. 8 -- committee
 discharged, bill amended, ordered reprinted as amended and recommitted
 to said committee

 AN ACT to amend the public health law and the state finance law, in
 relation to an emergency insulin program

 The People of the State of New York, represented in Senate and Assem-
 bly, do enact as follows:

 1 Section 1. The public health law is amended by adding a new article
 2 28-CC to read as follows:
 3 ARTICLE 28-CC
 4 EMERGENCY INSULIN PROGRAM
 5 Section 2894. Emergency insulin program.
 6 § 2894. Emergency insulin program. 1. The commissioner is authorized
 7 and directed to establish an emergency insulin program to ensure that
 8 recipients of the program can access emergency supplies of analog insu-
 9 lins and related supplies. The commissioner shall immediately engage
 10 analog insulin manufacturers to support the state program and facilitate
 11 quick access to affordable analog insulins in emergency situations. The
 12 commissioner shall establish standards for approval of any emergency
 13 insulin program, and analog insulin prescribing, dispensing, distrib-
 14 ution, and possession pursuant to this section which may include, but
 15 not be limited to, standards for program directors, appropriate clinical
 16 oversight, training, record keeping and reporting. The emergency insulin
 17 program shall, pursuant to an appropriation or sufficient funds in the
 18 emergency insulin program trust fund, be available to recipients no
 19 later than April first, two thousand twenty-seven.
 20 2. (a) As used in this section:

 EXPLANATION--Matter in italics (underscored) is new; matter in brackets
 [ ] is old law to be omitted.
 LBD03543-02-6

 S. 1917--A 2

 1 (i) "Analog insulins" means at a minimum short-acting, rapid-acting,
 2 intermediate and long acting insulin drugs approved by the Food and Drug
 3 Administration that, when administered, to certain recipients are life-
 4 saving, and help avoid serious adverse effects associated with type one
 5 diabetes and in some limited cases type two diabetes, and other medica-
 6 tions and supplies approved by the department for such purpose.
 7 (ii) "Health care professional" means a person licensed, registered or
 8 authorized pursuant to title eight of the education law to prescribe
 9 prescription drugs.
 10 (iii) "Pharmacist" means a person licensed or authorized to practice
 11 pharmacy pursuant to article one hundred thirty-seven of the education
 12 law.
 13 (iv) "Recipient" means a person: (1) diagnosed with type one diabetes,
 14 or type two insulin dependent diabetes; and (2) who is at risk of expe-
 15 riencing serious adverse health effects due to a lack of analog insu-
 16 lins; and (3) who is uninsured or underinsured; or (4) an organization
 17 registered as an emergency insulin program pursuant to this section.
 18 (b)(i) A health care professional may prescribe by a patient-specific
 19 or non-patient-specific prescription, dispense or distribute, directly
 20 or indirectly, analog insulins to a recipient.
 21 (ii) A pharmacist may dispense analog insulins, through a patient-spe-
 22 cific 

View New York S 1917 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.